These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2558699)

  • 1. Comparative potency of pipecuronium bromide and pancuronium bromide.
    Stanley JC; Mirakhur RK
    Br J Anaesth; 1989 Dec; 63(6):754-5. PubMed ID: 2558699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pipecuronium and pancuronium: comparison of pharmacokinetics and duration of action.
    Caldwell JE; Castagnoli KP; Canfell PC; Fahey MR; Lynam DP; Fisher DM; Miller RD
    Br J Anaesth; 1988 Dec; 61(6):693-7. PubMed ID: 2849968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative pharmacokinetics of pipecuronium bromide, pancuronium bromide and vecuronium bromide in anesthetized man].
    Yajima C; Sugai N; Hanaoka K; Numata K; Yamamoto K; Kushida Y; Murakami S; Yamamura H
    Masui; 1990 Jul; 39(7):882-9. PubMed ID: 1976829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and cardiovascular dynamics of pipecuronium bromide during coronary artery surgery.
    Wierda JM; Karliczek GF; Vandenbrom RH; Pinto I; Kersten-Kleef UW; Meijer DK; Agoston S
    Can J Anaesth; 1990 Mar; 37(2):183-91. PubMed ID: 2155718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular and cardiovascular effects of pipecuronium.
    Foldes FF; Nagashima H; Nguyen HD; Duncalf D; Goldiner PL
    Can J Anaesth; 1990 Jul; 37(5):549-55. PubMed ID: 1973636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular effects of pipecuronium bromide.
    Stanley JC; Mirakhur RK; Bell PF; Sharpe TD; Clarke RS
    Eur J Anaesthesiol; 1991 Mar; 8(2):151-6. PubMed ID: 1651856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pipecuronium and pancuronium on the isolated rabbit heart.
    Deam RK; Soni N
    Br J Anaesth; 1989 Mar; 62(3):287-9. PubMed ID: 2564784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
    Mirakhur RK
    Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-response evaluation of pipecuronium bromide in elderly patients under balanced anesthesia.
    Azad SS; Larijani GE; Goldberg ME; Beach CA; Marr AT; Seltzer JL
    J Clin Pharmacol; 1989 Jul; 29(7):657-9. PubMed ID: 2547848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and disposition of pipecuronium bromide in the cat.
    Agoston S; Vandenbrom RH; Wierda JM; Houwertjes MC; Kersten UW
    Eur J Anaesthesiol; 1988 Jul; 5(4):233-42. PubMed ID: 2848702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of pipecuronium bromide (Arduan) in elderly surgical patients.
    Ornstein E; Matteo RS; Schwartz AE; Jamdar SC; Diaz J
    Anesth Analg; 1992 Jun; 74(6):841-4. PubMed ID: 1317685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative potency of steroidal neuromuscular blocking drugs and isobolographic analysis of the interaction between rocuronium and other aminosteroids.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Jul; 75(1):37-42. PubMed ID: 7669466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics, urinary and biliary excretion of pipecuronium bromide.
    Wierda JM; Szenohradszky J; De Wit AP; Zentai G; Agoston S; Kakas M; Kleef UW; Meijer DK
    Eur J Anaesthesiol; 1991 Nov; 8(6):451-7. PubMed ID: 1662599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of succinylcholine on the pharmacodynamics of pipecuronium and pancuronium.
    Dubois MY; Fleming NW; Lea DE
    Anesth Analg; 1991 Mar; 72(3):364-8. PubMed ID: 1847278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular effect of pipecuronium bromide in infants and children during nitrous oxide-alfentanil anesthesia.
    Pittet JF; Tassonyi E; Morel DR; Gemperle G; Rouge JC
    Anesthesiology; 1990 Mar; 72(3):432-5. PubMed ID: 2155549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of pipecuronium bromide.
    Larijani GE; Bartkowski RR; Azad SS; Seltzer JL; Weinberger MJ; Beach CA; Goldberg ME
    Anesth Analg; 1989 Jun; 68(6):734-9. PubMed ID: 2544118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criteria for use of pancuronium bromide, vecuronium bromide, atracurium besylate, tubocurarine chloride, metocurine iodide, pipecuronium bromide, and doxacurium chloride in adults.
    Donnelly AJ; Golembiewski JA; Skupski R; Wojtynek JE
    Clin Pharm; 1992 May; 11(5):435-41. PubMed ID: 1349856
    [No Abstract]   [Full Text] [Related]  

  • 19. Pipecuronium-induced neuromuscular blockade during nitrous oxide-fentanyl, isoflurane, and halothane anesthesia in adults and children.
    Pittet JF; Tassonyi E; Morel DR; Gemperle G; Richter M; Rouge JC
    Anesthesiology; 1989 Aug; 71(2):210-3. PubMed ID: 2547325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects].
    Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K
    Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.